Methods and formulations for reducing circulating antibodies
申请人:——
公开号:US20010010818A1
公开(公告)日:2001-08-02
The invention provides methods for reducing circulating levels of antibodies, particularly disease-associated antibodies. The methods entail administering effective amounts of epitope-presenting carriers to an individual. In other embodiments, ex vivo methods for reducing circulating levels of antibodies are provided which employ epitope-presenting carriers.
Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same
申请人:——
公开号:US20020160964A1
公开(公告)日:2002-10-31
This invention provides conjugates useful for xenotransplantation which comprise a galactose &agr;1,3 galactosyl (&agr;Gal) epitope conjugated to a valency platform molecule, preferably a chemically defined valency platform molecule which allows precise valency. The invention also provides compositions comprising these conjugates, and methods (such as methods for inducing tolerance) using these conjugates and compositions.